ArticleNeurology(R) neuroimmunology & neuroinflammation2026
Myelin Oligodendrocyte Glycoprotein Antibodies in Breast Milk in a Lactating Woman With Severe Enterovirus-Associated MOGAD.
Article in Neurology(R) neuroimmunology & neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMyelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease (MOGAD) is a distinct neuroinflammatory disorder, which may be preceded by infections. Transmission of MOG-IgG from blood into breast milk has not been reported previously.
methodsWe present the case of a 38-year-old lactating woman with a severe manifestation of MOGAD after enterovirus gastroenteritis, who was still lactating at that time. Alongside with detailed clinical characteristics, we measured MOG-IgG in breast milk and serum from the breast-fed infant.
resultsOur patient experienced a severe progressive episode of CNS inflammation, affecting the optic nerve, brain, and spinal cord, before which she was partially breastfeeding. Her condition rapidly worsened to coma with status epilepticus, requiring intensive care admission. High serum MOG-IgG titers were detected and prompt attack therapy initiated with high-dose glucocorticosteroids followed by plasma exchange, which led to rapid clinical improvement. The patient's breast milk tested positive for MOG-IgG, whereas the serum of the breastfed infant was negative. DISCUSSION: Early diagnosis and therapeutic intervention at acute onset of MOGAD is important for attack remission. MOG-IgG may be detected in breast milk of lactating woman with MOGAD, but is probably not transmitted to the infant in detectable quantities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.